Khalili-Tanha Ghazaleh, Jamialahmadi Hamid, Rezaei-Tavirani Mostafa, Nazari Elham
Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran .
Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Gastroenterol Hepatol Bed Bench. 2024;17(4):338-348. doi: 10.22037/ghfbb.v17i4.2990.
This systematic review and meta-analysis aimed to assess the effect of hydrogen-rich water (HRW) on liver enzyme levels.
Liver disease is a significant global health concern, greatly affecting mortality rates. Elevated levels of liver enzymes, such as ALT, AST, ALP, and GGT are early symptoms of liver disorders, and various approaches can help reduce them. Recent studies have shown the prospective therapeutic advantages of hydrogen as an antioxidant and anti-inflammatory agent in many circumstances.
The search strategy was developed following PRISMA guidelines. PubMed, Google Scholar, and Embase were searched from the beginning to January 2024. Eight Randomized controlled trial (RCT) studies were included, encompassing 433 participants with various liver function disorders.
Our results showed a slight decrease in ALT, AST, and ALP levels in the treated group with HRW compared to the PW group.
Our findings suggest that consuming HRW may decrease liver enzyme levels in clinical populations. Further research is needed to confirm this relationship.
本系统评价和荟萃分析旨在评估富氢水(HRW)对肝酶水平的影响。
肝脏疾病是全球重大的健康问题,对死亡率有很大影响。谷丙转氨酶(ALT)、谷草转氨酶(AST)、碱性磷酸酶(ALP)和γ-谷氨酰转肽酶(GGT)等肝酶水平升高是肝脏疾病的早期症状,多种方法可帮助降低这些指标。最近的研究表明,在许多情况下,氢气作为一种抗氧化剂和抗炎剂具有潜在的治疗优势。
按照PRISMA指南制定检索策略。检索了从开始到2024年1月的PubMed、谷歌学术和Embase。纳入了8项随机对照试验(RCT)研究,涉及433名患有各种肝功能障碍的参与者。
我们的结果显示,与饮用普通水(PW)的组相比,饮用HRW的治疗组中ALT、AST和ALP水平略有下降。
我们的研究结果表明,饮用HRW可能会降低临床人群的肝酶水平。需要进一步研究来证实这种关系。